Infectious risks in patients with renal failure on hemodialysis. Importance of iron overload and deferoxamine
Hoen, B.; Kessler, M.
Presse Medicale 20(15): 681-682
1991
ISSN/ISBN: 0755-4982 PMID: 1828579 Document Number: 382799
Document emailed within 1 workday
Related Documents
Roxe, D.M.; Krumlovsky, F.A.; Del Greco, F.; Fitzsimons, E. 1990: Failure of deferoxamine to improve iron overload in chronic hemodialysis patients International Journal of Artificial Organs 13(4): 211-217Borgna-Pignatti, C.; Franchini, M.; Gandini, G.; Vassanelli, A.; De Gironcoli, M.; Aprili, G. 1998: Subcutaneous bolus injection of deferoxamine in adult patients affected by onco-hematologic diseases and iron overload Haematologica 83(9): 788-790
Marciani, M.G.; Cianciulli, P.; Stefani, N.; Stefanini, F.; Peroni, L.; Sabbadini, M.; Maschio, M.; Trua, G.; Papa, G. 1991: Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function Haematologica 76(2): 131-134
Quereda Rodríguez-Navarro, C.; Castilla Jiménez, J.; Marcen Letosa, R.; Garcia de Pesquera, F.; Maceira Cruz, B.; Delgado Zamora, R.; Fernández Andrade, C.; Martínez Martin, A.; Mateos Aguilar, J. 1977: Behavior of blood sugar, insulin, and growth hormone after oral glucose overload in patients with chronic renal failure under periodical hemodialysis Revista Clinica Espanola 147(1): 21-26
Bregman, H.; Gelfand, M.C. 1981: Iron overload in patients on maintenance hemodialysis International Journal of Artificial Organs 4(2): 56-57
Kessler, M.; Ferry, J.P.; Naoun, A.; Robert, J.; Huriet, C. 1981: Importance of bone scanning with Tc 99m in the supervision of hemodialysis patients with chronic renal failure Nephrologie 2(4): 171-175
Skorliakov, A.V.; Bystrenin, M.A.; Voloshinova, E.V. 2007: The character and structure of infectious complications in patients with chronic renal failure, who received or did not receive replacement therapy (hemodialysis) Klinicheskaia Meditsina 85(10): 59-61
Agroyannis, B.; Koutsicos, D.; Tzanatou-Exarchou, H.; Varsou-Papadimitriou, E.; Kapetanaki, A.; Yatzidis, H. 1991: Combined recombinant human erythropoietin-blood letting strategy for treating anemia and iron overload in hemodialysis patients International Journal of Artificial Organs 14(7): 403-406
Okada, K.; Kuno, T.; Yanai, M.; Maeda, H.; Takahashi, S.; Hatano, M. 1988: The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis Nihon Jinzo Gakkai Shi 30(8): 1053-1062
Fang, J.T.; Chen, Y.C.; Tien, Y.C.; Huang, C.C. 1998: Continuous venovenous hemodialysis in multiple organ systems failure patients with acute renal failure Changgeng Yi Xue Za Zhi 21(2): 146-151
Gokal, R.; Millard, P.R.; Weatherall, D.J.; Callender, S.T.; Ledingham, J.G.; Oliver, D.O. 1979: Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload Quarterly Journal of Medicine 48(191): 369-391
Gokal, R.; Millard, P.R.; Weatherall, D.J.; Callender, S.T.; Ledingham, J.G.; Oliver, D.O. 1979: Iron metabolism in haemodialysis patients. a study of the management of iron therapy and overload Quarterly Journal of Medicine 48(191): 369-391
Yoshida, M. 2002: Renal disease (renal failure, patients with hemodialysis) Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 6): 331-335
Bissoli, F.; Gini, G.; Bosio, M.; Ceriani, R. 1996: Concurrent use of phenytoin and furosemide: problems in a patient with congestive cardiac failure, chronic renal failure, liver cirrhosis and fluid overload Recenti Progressi in Medicina 87(5): 227-228
Igel-Korcagova, A.; Raab, P.; Brensing, K.A.; Pöge, U.; Klehr, H.-U.; Igel, M.; von Bergmann, K.; Sudhop, T. 2003: Cholesterol metabolism in patients with chronic renal failure on hemodialysis Journal of Nephrology 16(6): 850-854
de Gómez Dumm, N.T.; Giammona, A.M.; Touceda, L.A.; Raimondi, C. 2001: Lipid abnormalities in chronic renal failure patients undergoing hemodialysis Medicina 61(2): 142-146
Resende, L.A.L.; Caramori, J.C.T.; Kimaid, P.A.T.; Martin, L.C.; Barretti, P. 2002: The silent period in patients with chronic renal failure undergoing hemodialysis Electromyography and Clinical Neurophysiology 42(5): 275-279
De Francisco, A.L.M.; Sanjuán, F.; Foraster, A.; Fabado, S.; Carretero, D.; Santamaría, C.; Aguilera, J.; Alcalá, M.I.; Aljama, P. 2008: Epidemiological study on chronic renal failure elderly patients on hemodialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(1): 48-55
Korytowska, A.; Szmeja, Z. 1993: Smell and taste in patients with chronic renal failure treated by hemodialysis Otolaryngologia Polska 47(2): 144-152
Van der Vijgh, W.J. 1977: Pharmacokinetic aspects of digoxin in patients with terminal renal failure. II. on hemodialysis International Journal of Clinical Pharmacology and Biopharmacy 15(6): 255-259